Rare presentation of a rare disease erdheimchester disease. A case report 71 bone pain often localized to metaphysis and diaphysis was the most common symptom. Pdf erdheimchester disease ecd is a rare nonlangerhans. People with erdheimchester disease often have bone pain, especially in the lower legs and upper arms, due to an abnormal increase in bone density osteosclerosis. Erdheimchester disease is a rare nonlangerhans cell, nonfamilial multisystemic histiocytosis, with widespread manifestations and of highly variable severity. Ecd causes the overproduction of immune cells called histiocytes, which then accumulate in tissues and organs in the body. Because ecd is a rare disease, found mostly in men over 40 years of age, there is. Erdheimchester disease ecd is a rare form of non langerhans cell histiocytosis. It involves the excessive production of histiocytes, which are a type of white blood cell. Since the expert of the first symptoms the hope of life is a life of 19 months to 5 years, however i read several articles scientific report of some cases of people who have lived up to 30 years with the disease. A case of incidentallydiagnosed erdheimchester disease cureus. Erdheimchester disease is a rare type of slowgrowing blood cancer called a histiocytic neoplasm, which results in overproduction of cells called histiocytes. Erdheimchester disease ecd is a rare nonlangerhans cell histiocytosis that may present with pulmonary symptoms.
Erdheim chester disease ecd is a rare condition that can affect many parts of the body. Erdheimchester disease ecd is a rare, nonlangerhans histiocytosis described by jakob erdheim and william chester in 1930. It is a nonlangerhans form of histiocytosis, of unknown origin, and is rare. It was recently reported that a typical dosage for the treating of ecd with interferonalpha is an injection under the skin of 3miu, three times per week. Oral steroids, chemotherapy or radiotherapy in severe cases microscopic histologic description. Erdheimchester disease ecd is a rare, nonlangerhans histiocytosis. The condition seems to be nonfamilial and typically affects middleaged adults. Erdheimchester disease ecd is a rare multisystemic nonlangerhans cell histiocytosis that may be clonal and inflammatory in origin. Erdheimchester disease ecd is a rare nonlangerhans histiocytic disorder most commonly characterized by multifocal osteosclerotic lesions of the long bones demonstrating sheets of foamy histiocytes on biopsy, with or without histiocytic infiltration of extraskeletal tissues. Erdheimchester disease ecd is a rare type of nonlangerhans cell histiocytosis, with only 550 cases reported worldwide.
In erdheimchester disease, the excess production of histiocytes histiocytosis leads to inflammation that can damage organs and tissues. Histologically, it is characterized by a diffuse infiltration by foamy histiocytes of the tissues involved, causing a local xanthomatous or. In erdheimchester disease, the excess production of histiocytes histiocytosis leads to inflammation that can damage organs and tissues throughout the body, causing them to become thickened, dense, and scarred fibrotic. The disease was characterized by proliferation of lipidcontaining foamy histiocytes in the skeleton, especially in the long bones, without visceral involvement. Erdheim chester disease ecd is a rare multisystem disorder of adulthood. Consensus guidelines for the diagnosis and clinical management of. Ecd can cause severe lung disease, kidney failure, heart disease, and other complications that lead to death. Erdheimchester disease is a rare sporadic systemic histiocytic disease of unknown aetiology that affects multiple organ systems. Erdheimchester disease with no skeletal bone involvement. Thoracic, abdominal and musculoskeletal involvement in.
Ecd involves xanthomatous or xanthogranulomatous infiltration of tissues by foamy histiocytes, lipid. Erdheim chester disease ecd is a very rare disease in which abnormal white blood cells start growing and affect the bones, kidneys, skin, and brain. First described by william chester in 1930, erdheimchester disease ecd is a rare systemic disease characterized by xanthogranulomatous infiltration of the bones and organs by nonlangerhans foamy histiocytes. Orbital involvement is not infrequent and is manifested by exophthalmos and periorbital. It affects middle aged individuals and there is no sex predilection. Leenknegt, benjamin, julie dutoit, and koenraad verstraete. Erdheimchester disease genetics home reference nih. Erdheimchester disease an overview sciencedirect topics.
Dabrafenib and trametinib in people with braf v600e. Answers from specialists on erdheim chester disease life expectancy. Clinical and pathophysiological investigations into. It is no different from people without graves disease. Some of the signs and symptoms of lch overlap with ecd. Erdheimchester disease ecd is a rare nonlangerhans cell histiocytosis of. Erdheim chester disease is an extremely rare multisystem neoplasm characterized by. Eligible patients must have been diagnosed with erdheim chester disease, confirmed by pathological evaluation of the affected tissue with adequate staining. We read with interest the excellent study published by cavalli et al1 in annals of the rheumatic diseases and wish to voice our concerns. Pdf consensus guidelines for the diagnosis and clinical. The multi systemic form of ecd is associated with significant morbidity, which may arise due to histiocytic infiltration of critical organ systems. Click on the link and find out a little more, but what is interesting is that pathologists do not know how to classify this disease because it is so rare. Erdheimchester disease of the central nervous system.
Historically, ecd has been considered a variably aggressive histiocytic disorder of unclear origin with poor response. Diffuse infiltration of large, foamy histiocytes, lymphocytic aggregates and fibrosis. A rare histiocytic disorder characterised by lipoid granulomas in various parts of the body and in various organs. Erdheimchester disease is a rare, noninherited disease of middle age with a slight male predominance 6. Histiocytes are large phagocytic cells macrophages that normally play a role in responding to infection and injury. Erdheimchester disease is a rare form of nonlangerhans cell histiocytosis. Erdheimchester disease annals of the rheumatic diseases. Histiocytes are cells that usually respond to an injury or infection.
Erdheimchester disease is an extremely rare disorder that can affect many different organs of the body. Recent findings suggest that ecd is a clonal disorder, marked by recurrent brafv600e mutations in 50% of patients, in which chronic uncontrolled inflammation is an important mediator of disease pathogenesis. Consensus guidelines for the diagnosis and clinical. We report a fatal case of ecd with extensive cardiac involvement associated with a marginal zone lymphoma and monoclonal proteinemia in a young man. These cells, which are called histiocytes, infiltrate the loose connective tissue of. Erdheimchester disease ecd is a rare multisystem disorder of adulthood. These cells normally are responsible for responding to infection and injury. The primary characteristic of erdheimchester disease is the accumulation of histiocytes in multiple tissues and organs of the body. Erdheimchester disease ecd is a rare form of nonlangerhans cell histiocytosis that was initially described by william chester and his tutor, the viennese pathologist jakob erdheim, in 1930. Neurological manifestations of erdheimchester disease. It was discovered in 1930 by jacob erdheim and william chester. Individuals affected by this disease are typically adults between their 5th and 7th decades of life. Research about erdheimchester disease ecd 1 what approaches are made to detect what causes ecd. Erdheimchester disease ecd was first described as the lipoid granulomatose by jakob erdheim and his pupil william chester in 1930 1.
Parts of the body that may be involved include the long bones, retroperitoneum, skin, eyes and eyelids, lungs. It is characterized by excessive production and accumulation of histiocytes within multiple tissues and organs. The age of presentation of this disease is typically between 40 and 70 years. Consensus guidelines for the diagnosis and clinical management of erdheimchester disease.
Rare presentation of a rare disease erdheim chester. It is characterized by excessive production and accumulation of specific cells whose normal function is to fight infections. Erdheimchester disease associated with marginal zone. A case of generalized xanthogranuloma with systemic. Biliary manifestation of erdheimchester disease mimicking klatskin carcinoma am j gastroenterol 2007. Erdheim chester disease ecd is a rare type of histiocytosis disease that involves an excessive production and accumulation of a certain type of white blood cells histiocytes in many different organs of the body. Erdheimchester can involve many different systems in the body and most often affects the long bones. The etiology of this disease still remains unknown. Histiocytes normally function to destroy foreign substances and protect the body from infection. Additional and relevant useful information for erdheim chester disease. Erdheimchester disease radiology reference article. Erdheimchester disease ecd is a rare, nonlangerhans cell histiocytosis of unknown etiology, characterized by multi organ involvement. Erdheim chester disease life expectancy answers on healthtap.
Graves canshould be effectively treated and should have no. Ecd is a rare nonlangerhanscell histiocytosis, which can involve the cns. Living with erdheim chester disease can be difficult, but you have to fight to try to be happy. Genes associated with erdheimchester disease also linked.
Ecd was first described by erdheim and chester in 1930 1. First described in 1930 by william chester as a novel lipogranulomatous disorder, it was later termed erdheim chester disease after the pathologist erdheim, with whom he worked. Erdheimchester disease ecd is a rare, slow moving, multisystem blood cancer that is characterized by the excessive production and accumulation of a type of white blood cells called histiocytes. Diffuse reduction of cerebral grey matter volumes in erdheim. It has been diagnosed in children, but it most commonly affects adults. Erdheim chester disease ecd bears a close resemblance to langerhans cell histiocytosis lch, another disorder that is characterized by an excess proliferation of histiocytic cells, and affecting young children. Histiocytes are large cells that normally help in responding to infection or injury, but when they are in this. Erdheim chester disease nord national organization for. Pulmonary involvement is rare, its presentation is non. Cardiac involvement in erdheimchester disease circulation. Erdheimchester disease ecd is a rare form of histiocytosis of unknown origin characterized by tissue infiltration by lipidladen histiocytes. Erdheimchester disease ecd is a rare nonlangerhans histiocytosis characterized by systemic inflammation and granulomatous infiltration.
Erdheimchester disease ecd is a rare nonlangerhans histiocytosis that was first reported by jakob erdheim. Have a look at things that other people have done to be happy with erdheim chester disease world map of erdheim chester disease view more. The bottom line is, it is a disease in which there is an accumulation of histiocytes depositing themselves into loose connective tissue. Rg volume 31 number 4 rajiah et al 951 peritoneal masses are covered, grouped into solid. Erdheimchester disease is an extremely rare multisystem neoplasm characterized by. Typically, the diaphyseal and metaphyseal portions of the tubular bones are affected, leading to a characteristic radiographic pattern of bone sclerosis. Ecd is characterized by diffuse histiocytic infiltration of multiorgans. These cells, which are called histiocytes, infiltrate the loose connective tissue of the body. Erdheimchester disease symptoms histiocytosis association.
What is the life expectancy of someone with erdheim. Erdheimchester disease ecd is a rare nonlangerhans cell histiocytosis. Nonneoplastic masses include pseudotumoral lipomatosis, retroperitoneal fibrosis, erdheim chester disease, and extramedullary hematopoiesis. These cells, which normally help fight infection and injury, then gather in different organs and tissues and can result in a variety of symptoms, including organ failure. Newly identified genes associated with erdheimchester disease ecd, an ultrarare disease, are also linked to cancer, according to a new study.
Erdheimchester disease ecd was first described as the lipoid granulomatose by jakob erdheim and his pupil william chester in 1930. Pdf on jun 1, 2005, benjamin rhodes and others published erdheim chester disease find, read and cite all the research you need on researchgate. Although heterogeneity is the rule in the clinical presentation of patients with erdheimchester disease ecd, some manifestations should be regarded as diagnostic triggers of this condition. Consensus guidelines for the diagnosis and clinical management of erdheimchester disease article pdf available in blood 1244 may 2014 with 572 reads how we measure reads. In order of frequency, it also occurs in the kidney, retroperitoneum, skin, brain, lung, tissue behind the eyes, pituitary gland, and heart.
For patients with central nervous system cns or cardiac involvement, an injection under the skin of a high dosage of 69 miu, three times per week may be considered. Clinical manifestations range from asymptomatic to fatal multisystem involvement, typically. Frequently asked questions about erdheimchester disease ecd. Erdheimchester disease is an extremely rare pathological condition affecting multiple systems of the body which usually strikes in adulthood. Ecd erdheimchester disease fdg 2fluorine18 fluoro2deoxydglucose pet positron emission tomography lch langerhans cell histiocytosis introduction ecd is a rare, nonfamiliar disorder, first described by jakob erdheim and william chester in 1930 as lipid granulomatosis 1. See treatment of erdheimchester disease with longterm highdose interferon.
In fact erdheim chester is a rare nonlangerhans cell histiocytosis of unknown aetiology. Erdheimchester disease ecd is a rare condition that can affect many parts. Ecd clinical spectrum is particularly broad, and depends on the distribution and extent of the lesions. The cause was erdheimchester disease ecd, one of 7,000 diseases tracked by the nonprofit national organization for rare disorders. Erdheimchester disease is a rare form of nonlangerhanscell histiocytosis, firstly described by jakob erdheim and william chester in 1930 1. Historically, ecd has been considered a variably aggressive histiocytic disorder of unclear. Dramatic efficacy of vemurafenib in both multisystemic and refractory erdheimchester disease and langerhans cell histiocytosis harboring the braf v600e mutation. Erdheimchester disease is a systemic nonlangerhans histiocyte infiltration.
375 1277 150 294 588 1571 116 1146 1596 110 1473 494 460 628 889 1312 549 175 1213 422 1257 1556 589 1046 1420 183 826 110 551 1472 1253 1310 1250 1040 688 193 1207 1009 451 968 295 687